Perfil
Philip J.
Vickers currently serves as President, Chief Executive Officer & Director at Solu Therapeutics, Inc., Director at Northern Mosaic LP, and Director at Akebia Therapeutics, Inc. (starting 2026).
Former roles include President, Chief Executive Officer & Director at Northern Biologics, Inc. (2017–2020), President, Chief Executive Officer & Director at Faze Medicines, Inc. (2021–2022), President, Director & Chief Scientific Officer at Resolvyx Pharmaceuticals, Inc. (2009–2011), Independent Director at Revance Therapeutics, Inc. (2015–2023), Director at Neusentis Ltd., Independent Director at AVROBIO, Inc. (2019–2024), Global Head-Research & Development at Shire Plc (2013–2017), Principal at Boehringer Ingelheim Corp., VP & Head-Pfizer Research Technology Center at Pfizer (St. Louis), and Principal at Merck Research Laboratories Massachusetts LLC.
Education includes undergraduate studies at the University of Salford and a doctorate from the University of Toronto.
Cargos activos de Philip Vickers
| Empresas | Cargo | Inicio |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/04/2026 |
Northern Mosaic LP
Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Provides biotechnology technology services | Director/Miembro de la Junta | - |
Solu Therapeutics
Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Director Ejecutivo | 01/09/2023 |
Antiguos cargos conocidos de Philip Vickers.
| Empresas | Cargo | Fin |
|---|---|---|
| TECTONIC THERAPEUTIC, INC. | Director/Miembro de la Junta | 20/05/2024 |
| REVANCE THERAPEUTICS, INC. | Director/Miembro de la Junta | 03/05/2023 |
Faze Medicines, Inc. /MA)
Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Provides business services | Director Ejecutivo | 01/11/2022 |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Developing novel therapeutic antibodies for the treatment of human diseases in oncology and fibrosis | Director Ejecutivo | 01/12/2020 |
| SHIRE | Director Técnico/Científico/I+D | 01/06/2017 |
Formación de Philip Vickers.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 15 |
|---|---|
Resolvyx Pharmaceuticals, Inc.
Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for inflammatory diseases | Health Technology |
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
University of Salford
University of Salford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Neusentis Ltd.
Neusentis Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in other business support service activities | Commercial Services |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Developing novel therapeutic antibodies for the treatment of human diseases in oncology and fibrosis | Health Services |
AVROBIO, Inc.
AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Northern Mosaic LP
Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Provides biotechnology technology services | Commercial Services |
Faze Medicines, Inc. /MA)
Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Provides business services | Commercial Services |
Solu Therapeutics
Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Health Technology |
- Bolsa de valores
- Insiders
- Philip Vickers
















